Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 661-680
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Robert Holl Investor at Wellcome Trust | London, United Kingdom | Government-backed | AIHealthcare | View profile | |
Thor Nagel Bvf Partners, L.P at Biotechnology Value Fund | San Francisco, United States | Private equityVenture debt | Healthcare | View profile | |
Niklas Benedikt Grimm Researcher at Jazz Pharmaceuticals | Germany | Corporate VC | Healthcare | View profile | |
Srinivas Allanki Investor at The Francis Crick Institute | London, United Kingdom | Government-backed | AIHealthcare | View profile | |
Harshad Joshi Angel Investor at LVX | Qatar | Syndicate / Angel groupVenture capital | AICommerce | View profile | |
Kim Bruin Investor at Argenx | Amsterdam, Netherlands | Corporate VC | Healthcare | View profile | |
Angel L Cruz Echevarria Retail investor at Robinhood | Miami, United States | Corporate VCPrivate equity | AICommerce | View profile | |
Akash Pasi Investor at Medpace | Mumbai, India | Corporate VC | Healthcare | View profile | |
Sainitish Medishetti Founder in Residence at Entrepreneurs First | Hyderabad, India | AcceleratorVenture capital | AIHardware | View profile | |
Olivier Brossard Director, Private Equity and Impact Investing at Fonds de solidarité FTQ | Laval, Canada | Private equityVenture capital | AIClimate | View profile | |
Iris van Alderwerelt van Rosenburgh Bvf Partners, L.P at Biotechnology Value Fund | San Francisco, United States | Private equityVenture debt | Healthcare | View profile | |
Samuel Wilkins Affiliated at Otago Innovation | New Zealand | Accelerator | Healthcare | View profile | |
Vincenzo Francia Venture Partner at NextSTEP | London, United Kingdom | AcceleratorCorporate VC | AIClimate | View profile | |
Syama Bunten Managing Director at Green Sands Equity | San Francisco, United States | Corporate VCPrivate equity | AIClimate | View profile | |
Bruno Holthof Chair of the Supervisory Board Health and Care Fund at Gimv | Oxford, United Kingdom | Family OfficePrivate equity | AIClimate | View profile | |
Ludovic Copéré Senior Investment Director, Sony Ventures at Sony Innovation Fund | San Francisco, United States | Corporate VCPrivate equity | AIConsumer | View profile | |
Brennan Lim President at Berkeley Venture Capital | San Francisco, United States | AcceleratorPrivate equity | AICommerce | View profile | |
Enrico Carbone Managing Partner at IKJ Capital | Palo Alto, United States | Syndicate / Angel groupVenture capital | AICommerce | View profile | |
Garri Zmudze General partner at LongeVC | Beverly Hills, United States | AngelOperator angel | AIHealthcare | View profile | |
Michael Antonov Founder at Formic Ventures | San Francisco, United States | AngelOperator angel | AIFinTech | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
